EagleClaw Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$16.1M |
| 2 |
eBay
EBAY
|
+$5.35M |
| 3 |
Charles River Laboratories
CRL
|
+$1.55M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.45M |
| 5 |
ConocoPhillips
COP
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2M |
| 2 |
WRK
WestRock Company
WRK
|
+$784K |
| 3 |
Home Depot
HD
|
+$594K |
| 4 |
KSU
Kansas City Southern
KSU
|
+$467K |
| 5 |
Aramark
ARMK
|
+$437K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.7% |
| 2 | Consumer Discretionary | 20.22% |
| 3 | Financials | 12.39% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 10.61% |
Similar funds
EagleClaw Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, EagleClaw Capital Management held 146 positions worth $456M, up 18% from $388M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
EagleClaw Capital Management deployed $32.6M of net new capital in Q4 2021, opening 10 new positions and adding to 59 existing holdings. Its largest new stake was eBay: 75,000 shares worth $75K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $2M trimmed.
- EagleClaw Capital Management's largest Q4 2021 buy was eBay: 75,000 shares worth $75K.
- EagleClaw Capital Management added most to Nike in Q4 2021, an estimated $16.1M increase.
- EagleClaw Capital Management's biggest Q4 2021 reduction was Gilead Sciences, cutting an estimated $2M.
- EagleClaw Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $467K.
- EagleClaw Capital Management's ten largest holdings make up 37% of its $456M portfolio in Q4 2021.
- EagleClaw Capital Management opened 10 new positions and closed 4 in Q4 2021.
- EagleClaw Capital Management's portfolio value rose 18% quarter-over-quarter to $456M.
Based on EagleClaw Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.